The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
This acquisition is expected to enhance Boston Scientific's (BSX) market position and revenue streams in North America and Europe.
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to gain from the favorable factors.
The latest trading day saw Boston Scientific (BSX) settling at $76.31, representing a +0.16% change from its previous close.
Shares of Silk Road Medical (SILK) soared in intraday trading Tuesday after Boston Scientific (BSX) announced it was buying the medical device maker for about $1.26 billion.
Tuesday, Boston Scientific Corporation BSX agreed to acquire Silk Road Medical Inc SILK for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.
Boston Scientific will pay $27.50 a share, or $1.16 billion, for Silk Road Medical.
Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.
In the most recent trading session, Boston Scientific (BSX) closed at $77.41, indicating a +0.34% shift from the previous trading day.
In the latest trading session, Boston Scientific (BSX) closed at $75.57, marking a +0.76% move from the previous day.
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?